BSEBrawn Biotech LtdMinimalNeutral
Announced Wed, 8 Jul · 15:49 IST

Routine quarterly compliance certificate under SEBI Reg 74(5)

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.6%1-day move
₹22.58
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-2.6-7.4-9.2-11.4-2.3
Up moveDown movePending
AI summary

Brawn Biotech filed a certificate from its Registrar and Share Transfer Agent, RCMC Share Registry, confirming compliance with SEBI Regulation 74(5) for the quarter ended June 30, 2026. The certificate verifies that shares received from depository participants for dematerialisation were properly accepted or rejected, listed on the stock exchanges, and that physical certificates were mutilated and cancelled within 15 days, with the depository name recorded as the registered owner. This is a standard procedural filing.

Likely market impact

No material impact. Routine quarterly compliance with no effect on operations, financials, or share price.